Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 48NIH 4OTHER_GOV 3NETWORK 2INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 2Breast 2

Conditions

Breast Neoplasms 2550Triple Negative Breast Neoplasms 435Carcinoma, Non-Small-Cell Lung 338Ovarian Neoplasms 315Neoplasms 280Neoplasm Metastasis 253Colorectal Neoplasms 245Stomach Neoplasms 202Pancreatic Neoplasms 196Prostatic Neoplasms 188Lung Neoplasms 180Melanoma 171Squamous Cell Carcinoma of Head and Neck 140Endometrial Neoplasms 140Head and Neck Neoplasms 124Carcinoma, Renal Cell 118Uterine Cervical Neoplasms 104Esophageal Neoplasms 97Urinary Bladder Neoplasms 92Small Cell Lung Carcinoma 87Sarcoma 84Colonic Neoplasms 80Carcinoma, Hepatocellular 62Carcinoma, Transitional Cell 61Kidney Neoplasms 51Advanced Breast Cancer 51Cholangiocarcinoma 50Liver Neoplasms 47Brain Neoplasms 43Mesothelioma 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Hereditary Breast and Ovarian Cancer Syndrome × Breast × Clear all
NCT04668521 2023-12-26

OVA360

Aspira Women's Health

Terminated
215 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT01273909 2014-06-06

Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment

The National Institute of Lymphology

Unknown
1,000 enrolled
BreastGynecologic

Breast Neoplasms, Lymphedema, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡